Login
Super Investors JNL/Mellon Healthcare Sector Fund

JNL/Mellon Healthcare Sector Fund

Jnl Variable Fund LLC · net assets $2.78B · 362 holdings as of March 31, 2020. Monthly N-PORT disclosure: the full book, not just equities.

Asset mix

EC: 97.3% · STIV: 2.7% · DE: 0.0%

Financial position

Total assets
$2.84B
Total liabilities
$57.5M
Net assets
$2.78B
Assets attributable to miscellaneous securities
$0
Assets invested in controlled foreign corporations
$0
Borrowings payable within one year
$0
Payable to controlled companies within one year
$0
Payable to other affiliates within one year
$0
Other liabilities payable within one year
$0
Borrowings payable after one year
$0
Payable to controlled companies after one year
$0
Payable to other affiliates after one year
$0
Other liabilities payable after one year
$0
Payables for delayed-delivery investments
$0
Payables for standby commitments
$0
Liquidation preference of outstanding preferred stock
$0
Cash not reported in Parts C or D
$1.23M

Monthly flows and gains

Month 1 Month 2 Month 3
Sales $39.6M $35.7M $58.1M
Reinvestment $0 $0 $0
Redemptions $73.9M $89.8M $102M
Net realized gain (non-derivative) $16.1M $12.7M $23.2M
Net unrealized appreciation (non-derivative) $-106M $-213M $-175M

The three months of the reporting period, as filed; month 3 ends March 31, 2020.

Filing details

Registrant
Jnl Variable Fund LLC
Registrant CIK
1072428
Registrant LEI
5493004N5OZUYMBW0M40
Series
JNL/Mellon Healthcare Sector Fund
Series ID
S000001697
Series LEI
54930024HJBJ7HNLBO26
SEC file number
811-09121
Address
1 Corporate Way, Lansing, US-MI, 48951, US
Phone
517-367-4336
Form
NPORT-P
Filed
May 29, 2020
Report period ends
December 31, 2020
Report month ends
March 31, 2020
Accession number
000114554920031152
Holding Value % of net assets
Johnson & Johnson EC $247M 8.88%
Unitedhealth Group Incorporated EC $169M 6.08%
Merck & Co., Inc. EC $140M 5.04%
Pfizer Inc. EC $129M 4.65%
Abbott Laboratories EC $100M 3.59%
Bristol-myers Squibb Company EC $93.6M 3.36%
Medtronic Public Limited Company EC $86.6M 3.11%
Amgen Inc. EC $86.3M 3.10%
Eli Lilly And Company EC $85.9M 3.08%
Thermo Fisher Scientific Inc. EC $81.5M 2.93%
Abbvie Inc. EC $80.7M 2.90%
Gilead Sciences, Inc. EC $67.7M 2.43%
Danaher Corporation EC $62M 2.23%
Cvs Health Corporation EC $55.3M 1.99%
Jackson National Asset Management, LLC STIV $54.8M 1.97%
Cigna Holding Company EC $47.5M 1.70%
Becton, Dickinson And Company EC $44.6M 1.60%
Vertex Pharmaceuticals Incorporated EC $43.9M 1.58%
Allergan Public Limited Company EC $41.7M 1.50%
Anthem, Inc. EC $41.3M 1.48%
Intuitive Surgical, Inc. EC $41M 1.47%
Biogen Inc. EC $40.9M 1.47%
Stryker Corporation EC $40.2M 1.45%
Zoetis Inc. EC $40.2M 1.44%
Boston Scientific Corporation EC $32.6M 1.17%
Humana Inc. EC $29.8M 1.07%
Illumina, Inc. EC $28.8M 1.03%
Regeneron Pharmaceuticals, Inc. EC $28.3M 1.02%
Baxter International Inc. EC $28.2M 1.01%
Edwards Lifesciences Corporation EC $28.2M 1.01%
Centene Corporation EC $24.9M 0.89%
Jnl Government Money Market Fund STIV $18.3M 0.66%
Dexcom, Inc. EC $17.6M 0.63%
Hca Healthcare, Inc. EC $17.5M 0.63%
Agilent Technologies, Inc. EC $15.9M 0.57%
Mckesson Corporation EC $15.6M 0.56%
Resmed Inc. EC $15.2M 0.54%
Zimmer Biomet Holdings, Inc. EC $14.9M 0.53%
Idexx Laboratories, Inc. EC $14.9M 0.53%
Veeva Systems Inc. EC $14.7M 0.53%
Alexion Pharmaceuticals, Inc. EC $14.2M 0.51%
Cerner Corporation EC $14.2M 0.51%
Iqvia Inc. EC $12.7M 0.46%
Mettler-toledo International Inc. EC $12.1M 0.43%
Biomarin Pharmaceutical Inc. EC $10.8M 0.39%
Cardinal Health, Inc. EC $10.1M 0.36%
Seattle Genetics, Inc. EC $9.95M 0.36%
The Cooper Companies, Inc. EC $9.77M 0.35%
Amerisourcebergen Corporation EC $9.75M 0.35%
Teleflex Incorporated EC $9.7M 0.35%
Incyte Corporation EC $9.57M 0.34%
Align Technology, Inc. EC $9.29M 0.33%
Laboratory Corporation Of America Holdings EC $8.75M 0.31%
Alnylam Pharmaceuticals, Inc. EC $8.72M 0.31%
Steris Limited EC $8.56M 0.31%
Waters Corporation EC $8.43M 0.30%
West Pharmaceutical Services, Inc. EC $8.12M 0.29%
Quest Diagnostics Incorporated EC $7.71M 0.28%
Teladoc Health, Inc. EC $7.67M 0.28%
Insulet Corporation EC $7.31M 0.26%

Showing top 60 of 362 holdings.

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support